In this podcast interview, Scott MacLean talks about “the fundamental infrastructure” that enables MedStar to deliver quality care, why he sought a position on CHIME’s Board of Trustees, and the enormous impact individuals can have by taking community walks.
In this podcast, Scott MacLean talks about how MedStar is carrying out its post-Covid strategy, the “never-ending battle” to keep systems upgraded and refreshed, and why the digital front door is about so much more than a portal.
A prominent CIO of a regional hospital system encountered the limitations of HIPAA and so-called “Protected Health Information (PHI)” when her boss fired her after a short medical leave of absence. After years working without taking vacation, a family catastrophe that affected her health prompted her to take a medical leave of absence. She had […]
The FDA has been receiving a great deal of criticism from the clinical community about a variety of issues, but probably none is as contentious as the ongoing patient safety issues regarding harmful drug-drug interactions and drug-gene interactions, estimated by the Institute of Medicine to cause 250,000 deaths each year in the U.S. The current […]
Individualizing drug therapy based on pharmacogenomics (PGx) is considered by many academic researchers and clinical experts as the “next significant domain of clinical practice” (see the American College of Clinical Pharmacology’s very informative web-based tutorial, “The Future of Medicine: Pharmacogenomics”, http://user.accp1.org/index_new.html). Drugs that are currently recommended for PGx testing by the FDA include specific medications […]